This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts

Products

View more
About Beyonttra®▼ (acoramidis)
Learn more about Beyonttra® (acoramidis).
PP-BEY-IE-0031-1, November 2025
About NUBEQA® (darolutamide)
Access key information about NUBEQA® (darolutamide).
PP-NUB-IE-0264-1, December 2025
Kyleena® (19.5mg Levonorgestrel)
Discover information about Kyleena's intended usage.
PP-KYL-IE-0252-1, January 2026
About EYLEA® (aflibercept) 8mg
Discover data and resources about EYLEA 8mg.
PP-EYL_8mg-IE-0150-1, January 2026

Create an account

Personalise your experience, stay up to date with additional resources and keep up to date via electronic communications from Bayer PLC.